Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics
Company Details
- Employees
- 39
- Founded
- -
- Address
- 134 Coolidge Ave, Watertown,massachusetts 02472,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://portal.bio/
- HQ
- Watertown, Massachusetts
Portal Questions
Portal's website is https://portal.bio/
Portal's LinkedIn profile is https://www.linkedin.com/company/portal-bio
Portal has
39 employees.
View email and phone details for 39
employees at Portal.
Portal's industry is
Biotechnology Research
Portal's top competitors are
Manifold Bio,
Kytopen,
Incendia Therapeutics,
Qld Biotherapeutics Inc,
Nona Biosciences,
Pledge Therapeutics,
Spear Bio,
Marengo Therapeutics,
1910 Genetics,
Vivtex.
Portal's categories are Biotechnology Research
Portal's founding year is 2023
